Bringing Rationalism to Empiricism: A Discussion on Empiric SBRT for Early-Stage Lung Cancer
Lung cancer screening is resulting in a higher incidence of early-stage lung cancer diagnoses. This commonly occurs among older patients with chronic lung disease who are at high risk for complications with attaining pathologic confirmation.
Category
  • SBRT
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Certificate of Attendance
Cost $149.00
Pushing the Boundaries: Re-Irradiation for Pediatric Brain Tumors
Over the last 10 years, new studies have emerged demonstrating efficacy and safety of re-irradiation for children with recurrent brain tumors.
Category
  • Central Nervous System
  • Pediatric
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
The Role for Consolidative Local Therapy in Stage IV Non-Small Cell Lung Cancer for Oligometastases and Beyond: How are We Improving Outcomes for Patients?
Patients with Stage IV Lung cancer vary in their response to the numerous systemic therapies and are living longer. The role of aggressive local therapy or metastatic directed therapy (MDT) is critical for radiation oncologists and surgeons.
Category
  • Oligometastatic
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Radiotherapy for Leukemia: Past, Present and Future
The use of radiotherapy (RT) in the management of leukemia has evolved. Historically, RT was critical for disease control in sanctuary sites, such as the central nervous system (CNS) and testes.
Category
  • Pediatric
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Advances in Sarcoma Treatment
Sarcomas are a rare and heterogenous group of malignancies requiring a multidisciplinary approach for optimal management.
Category
  • Sarcoma
Format
  • onDemand
  • Webinars
Credits
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 Certificate of Attendance
Cost $299.00
2025 ASTRO Annual Refresher Course onDemand
This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most major subdisciplines of radiation oncology, including sarcomas, pediatrics and lymphomas, and the role of radiotherapy in the multidiscipli
Category
Format
  • Meetings onDemand
Credits
  • 24.25 AMA PRA Category 1 Credit™
  • 24.25 Certificate of Attendance
Cost $1,049.00
2026 Multidisciplinary Radiopharmaceutical Therapy Symposium onDemand
The 2026 Multidisciplinary Radiopharmaceutical Therapy Symposium is a two-day meeting featuring interactive and case-based educational sessions that focus on the evolving utilization of and advancements in radiopharmaceuticals in the treatment of cancer and other indications.
Category
  • Radiopharmaceutical Therapy
Format
  • Meetings onDemand
Credits
  • 13.25 AMA PRA Category 1 Credit™
  • 13.25 Certificate of Attendance
Cost $1,799.00
A Case-based Guide for World Health Organization (WHO) Grade 2 Meningioma Radiosurgery and Radiotherapy from The Radiosurgery Society
This journal activity presents consensus effort guidelines for managing meningioma with radiotherapy.Please visit this LINK to read the related journal article online. 
Category
  • Central Nervous System
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
A Randomized Study of Consolidation Chemoradiation (CTRT) versus Observation after first line chemotherapy (CT) in Advanced Gall Bladder Cancers (GBC): Race-GB Study
Management of unresectable gall bladder cancer (GBC) is challenging, and it can be especially so in Low-to-Middle Income Countries (LMIC), as <50% of patients complete the standard 6 cycles of CT.  This article presents the results of a single center, open label, randomized trial evaluating co
Category
  • Gastrointestinal
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $49.00
Appropriateness Criteria for Radiotherapy in the Setting of Presumed Early-stage Lung Cancer
This activity provides practitioners with the knowledge of the treatment of lung mass without tissue diagnosis.
Category
  • Thoracic
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00

Pages